SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001185185-24-000676
Filing Date
2024-07-09
Accepted
2024-07-09 14:17:37
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A igcpharma20240709_defa14a.htm DEFA14A 25182
2 igc20240709_defa14aimg001.jpg GRAPHIC 2144
3 igc20240709_defa14aimg002.jpg GRAPHIC 9254
4 igc20240709_defa14aimg003.jpg GRAPHIC 11247
5 igc20240709_defa14aimg004.jpg GRAPHIC 2048
6 igc20240709_defa14aimg005.jpg GRAPHIC 899
  Complete submission text file 0001185185-24-000676.txt   62259
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-32830 | Film No.: 241107198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)